VisionPoint Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $683K | Buy |
3,679
+1,556
| +73% | +$289K | 0.15% | 152 |
|
|
2025
Q1 | $445K | Buy |
2,123
+473
| +29% | +$99.1K | 0.15% | 121 |
|
|
2024
Q4 | $296K | Sell |
1,650
-271
| -14% | -$48.6K | 0.1% | 144 |
|
|
2024
Q3 | $379K | Sell |
1,921
-546
| -22% | -$108K | 0.13% | 124 |
|
|
2024
Q2 | $423K | Sell |
2,467
-4,480
| -64% | -$768K | 0.15% | 115 |
|
|
2024
Q1 | $1.27M | Sell |
6,947
-3,311
| -32% | -$603K | 0.46% | 62 |
|
|
2023
Q4 | $1.59M | Buy |
10,258
+634
| +7% | +$98.3K | 0.59% | 50 |
|
|
2023
Q3 | $1.43M | Buy |
9,624
+201
| +2% | +$30K | 0.62% | 49 |
|
|
2023
Q2 | $1.27M | Sell |
9,423
-857
| -8% | -$115K | 0.52% | 56 |
|
|
2023
Q1 | $1.51M | Sell |
10,280
-3,455
| -25% | -$509K | 0.67% | 41 |
|
|
2022
Q4 | $2.11M | Buy |
13,735
+6,005
| +78% | +$923K | 0.87% | 31 |
|
|
2022
Q3 | $1.04M | Buy |
7,730
+199
| +3% | +$26.7K | 0.5% | 29 |
|
|
2022
Q2 | $1.07M | Sell |
7,531
-1,237
| -14% | -$176K | 0.42% | 39 |
|
|
2022
Q1 | $1.35M | Buy |
+8,768
| New | +$1.35M | 0.63% | 38 |
|
|
2021
Q1 | – | Sell |
-2,038
| Closed | -$218K | – | 114 |
|
|
2020
Q4 | $218K | Sell |
2,038
-5,432
| -73% | -$581K | 0.11% | 130 |
|
|
2020
Q3 | $654K | Sell |
7,470
-3,229
| -30% | -$283K | 0.28% | 49 |
|
|
2020
Q2 | $1.04M | Buy |
10,699
+7,544
| +239% | +$733K | 0.42% | 34 |
|
|
2020
Q1 | $240K | Sell |
3,155
-450
| -12% | -$34.2K | 0.11% | 96 |
|
|
2019
Q4 | $319K | Sell |
3,605
-1,026
| -22% | -$90.8K | 0.13% | 82 |
|
|
2019
Q3 | $346K | Buy |
4,631
+1,133
| +32% | +$84.7K | 0.09% | 86 |
|
|
2019
Q2 | $254K | Buy |
3,498
+40
| +1% | +$2.91K | 0.07% | 110 |
|
|
2019
Q1 | $279K | Buy |
+3,458
| New | +$279K | 0.08% | 105 |
|